Published on : Nov 01, 2017
Albany, New York, November 1, 2017: The advent of artificial intelligence (AI) has benefitted the medical sector in several ways. It has an impact on patients, doctors, hospitals, clinical facilities, and the healthcare industry overall. Analysts find that the future is bright in the field of cancer research and treatment. Immunotherapy is currently revolutionizing cancer treatment and it has the potential to improve patient outcomes significantly in the future and is now used with artificial intelligence technology. Recently, Market Research Hub (MRH) has broadcasted a new study to its mega-repository, which is titled as “Cancer Immunotherapy with Artificial Intelligence for Hospitals: Market Shares, Strategies, and Forecasts, Worldwide, 2017 to 2023”. The study entirely focuses on the worldwide market of pancreatic cancer diagnostics, analyzing its trends, understanding market dynamics and forecasting its future growth from 2017 to 2023.
Immunotherapy works better for certain types of cancer over others. It is sometimes used as the only treatment and other times in conjunction with other treatments. New strategies are being developed by companies to bring A.I. to healthcare, which as a result contributing to its market growth. The study further adds that automated cancer immunotherapies from IBM Watson are employed with artificial intelligence that looks at patient samples to detect the genetic characteristics of cancer and isolate the immune particularities of the patient.
According to the study key findings, Cancer immunotherapy hospital artificial intelligence market system shipments were valued at $7.4 billion in 2017, and are forecast to reach $49.4 billion dollars, worldwide by 2023. Some of the prime factors currently driving worldwide market growth include the benefits of artificial intelligence software which increases diagnostic excellence, saving lives and lowering care delivery costs. These artificial intelligence systems represent a very specialized type of care delivery. Also, personalized medicine is driving this market opportunity.
Cancer therapy research institutions that use artificial intelligence (AI) algorithms are proliferating. It has been analyzed in the study that Immunotherapy at Memorial Sloan Kettering (MSK) has been making enormous progress in the treatment of cancer. At Memorial Sloan Kettering, immunotherapy is one of the most promising ways to treat, cure, and ultimately prevent cancer. Immunotherapy at MSK has evolved new immune-based treatments for cancer, thus contributing towards market growth.
Moreover, a thorough and insightful analysis of the key companies operating in the global pancreatic cancer diagnostics using artificial intelligence for hospitals market has been offered to the readers. At present, market leaders include IBM and General Electric. Other market participants are Quest Diagnostics, Alphabet / Google, Prognos, GlaxoSmithKline (GSK), Zebra, Merck and Safeguard Scientifics.
Request a Sample with TOC in a PDF format : https://www.marketresearchhub.com/enquiry.php?type=S&repid=1358742
About Market Research Hub
Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.
MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.
For Enquiries, Call :
+1-800-998-4852US Toll Free
Email : email@example.com